Brilacidin is under clinical development by Innovation Pharmaceuticals and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

The multivalent toxoid vaccine candidate from LimmaTech Biologics AG is designed to prevent skin and soft-tissue infections ...

"Staphylococcus aureus infections are a major cause of global mortality and morbidity, with traditional antibiotic treatments ...

Manuka honey comes from the manuka plant, officially known as Leptospermum scoparium. The plant is a bush native to New ...

In the United States, Zevtera is indicated for the treatment of adult patients with Staphylococcus aureus bloodstream infections (bacteremia) (SAB), including right-sided infective endocarditis, and ...

A surgical site infection (SSI) is an infection that happens where you had surgery. SSIs happen in 2% to 4% of people who ...

Despite this, Dr Zac warns that there are still risks when using dirty gym equipment. Gyms can be a breeding ground for bacteria and fungi, but mostly the kind that causes skin infections rather than ...

Staphylococcus aureus (S. aureus) is a major cause of skin and soft tissue infections that can sometimes lead to sepsis and toxic shock syndrome. The microbe poses a significant threat to public ...

“It is a pathogen in dire need of control because it causes significant morbidity and mortality not just in the United States ...

These are white blood cells that detect infections and activate other immune cells to attack and kill pathogens. The ...

Innoviva Specialty Therapeutics, Inc., ("IST") a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced it has entered ...